MEDICINA
Departamento
Klinikum der Universität München
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Klinikum der Universität München (16)
2024
-
Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: The EuroSMR risk score
European Heart Journal, Vol. 45, Núm. 11, pp. 922-936
-
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272
-
Dual disorder: does expert clinical experience support the rationale for cariprazine use?
European Review for Medical and Pharmacological Sciences, Vol. 28, Núm. 5, pp. 2095-2106
-
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 2, pp. 205-217
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Identifying Early Infections in the Setting of CRS with Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL
HemaSphere, Vol. 7, Núm. 4, pp. E858
-
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Blood
-
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL
American Journal of Hematology, Vol. 98, Núm. 11, pp. 1699-1710
2022
-
Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
Annals of Oncology, Vol. 33, Núm. 3, pp. 259-275
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
Blood Advances
-
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Blood, Vol. 140, Núm. 11, pp. 1229-1253
2020
-
Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study
British Journal of Haematology, Vol. 188, Núm. 5, pp. 745-756
2017
-
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367
2010
-
Quality, quantity and harmony: The DataSHaPER approach to integrating data across bioclinical studies
International Journal of Epidemiology, Vol. 39, Núm. 5, pp. 1383-1393
2006
-
Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia
Journal of the National Cancer Institute, Vol. 98, Núm. 4, pp. 273-284